Evaluation of Peer Group Connection - Middle School
The Policy & Research Group · with Department of Health and Human Services, Mathematica Policy Research, Inc. · NCT06582641
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 11–14 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1400
- US sites recruiting
- 1
- Study start
- September 1, 2024
- Record last updated
- May 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is a randomized controlled trial to assess the impact of the Peer Group Connection - Middle School (PGC-MS) intervention on pre-sexual behaviors and sexual initiation in middle school-aged youth. The primary research questions it aims to answer are:
- What is the impact of the offer to participate in PGC-MS relative to the control group on participants' reported initiation of sexual intercourse at sixteen months post-intervention?
- What is the impact of the offer to participate in PGC-MS relative to the control group on participants' reports of ever smoking a cigarette at four months post-intervention?
- What is the impact of the offer to participate in PGC-MS relative to the control group on participants' reports of ever using an electronic vapor product at four months post-intervention?
- What is the impact of the offer to participate in PGC-MS relative to the control group on participants' reports of ever having a drink of alcohol at four months post-intervention?
- What is the impact of the offer to participate in PGC-MS relative to the control group on participants' reports of ever using marijuana at four months post-intervention?
Researchers will compare participants randomized to receive PGC-MS (treatment group) to participants randomized to class-as-usual (which contains no sexual or reproductive health information (control group)).
Participants randomized to the treatment group will be offered PGC-MS over the course of their transition year into middle school (6th grade). Participants randomized to the control group will be offered class-as-usual.
Being studied: Peer Group Connection - Middle School (PGC-MS)
Conditions: Teen Pregnancy Prevention
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Be enrolled at a middle school participating in the study
- Entering the middle school transition grade for the first time (6th or 7th grade depending on the middle school transition year) at a participating study school
- Provide parental consent and student assent to participate in the study
- Have the ability to complete a self-administered questionnaire in either English or Spanish in a classroom or group setting, unassisted, in 60 minutes or less.
Exclusion Criteria
- Repeating the middle school transition year (6th or 7th grade)
Recruiting US locations
The Policy & Research Group
New Orleans, LA 70118
Site contact: Hilary Demby, MPH · 504-865-1545 · hilary@policyandresearch.com
Study contacts (from the official record)
- Hilary Demby, MPH · 504-655-0982 · hilary@policyandresearch.com
- Kelly Burgess, MPH · 225-773-9162 · kelly@policyandresearch.com
Similar studies in Louisiana
All pregnancy studies in Louisiana →- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- New Orleans, LA + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Covington, LA + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Metairie, LA + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- New Orleans, LA + 21 other US sites
- Eligibility basics
- Ages 2–17